Nath Bio-Genes (India) Limited has informed the Exchange about General Updates Investor Presentation on financial Results as on 31st December 2025
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes has filed an Investor Presentation with the stock exchange covering its financial results for the quarter ended 31st December 2025. This is a routine corporate disclosure where the company shares key financial highlights and business updates with investors. The presentation itself was not included in the filing summary, so specific numbers cannot be confirmed. The filing simply notifies the exchange that the presentation has been shared with analysts and investors.
This is a standard regulatory disclosure and is informational in nature. Shareholders may want to review the detailed presentation for any forward-looking guidance, but the filing itself does not signal any material change in business outlook or operations.